EXPLORE OUR COMMUNITY

DATAN

For more than 38 years, DATAN has been a trusted partner for biostatistics in the pharmaceutical industry, bringing expertise from over 500 clinical trials. With their agile team of highly qualified statisticians and mathematicians, DATAN supports clients with tailored statistical analyses and consulting services for clinical trials of all phases and sizes, across a broad spectrum of therapeutic areas. DATAN combines scientific rigor with efficiency. Using industry-standard tools such as SAS and R, they ensure that every project is conducted under a robust quality management system (SOPs) and in full compliance with all relevant industry standards, providing clients with high-quality, dependable insights that drive the success of their clinical research.

In addition, their DATAN Analytics AI+ Platform helps make clinical trials more efficient and therefore more cost-effective. With the support of this platform, processes can be automated and tasks such as generating documents and reports can be completed with ease. The DATAN Analytics AI+ Platform is built on a dedicated and secure virtual server, ensuring that users retain 100% control of their data. When applying AI models—currently around ten different models with diverse capabilities—no data is ever used to train competitors’ large language models or transferred abroad. As a result, the daily work becomes significantly more efficient without compromising on data protection or compliance.

LEARN MORE

Websitedatan.deCountryGermanyTypeCompany

JOIN THE SYSTEMS & NETWORK MEDICINE REVOLUTION
IN DRUG REPURPOSING

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. This work was also partly supported by the Swiss State Secretariat for Education, Research, and Innovation (SERI) under contract No. 22.00115.